Preparation and Clinical Assessment of Spironolactone-Containing Cream on Hair Growth in Hirsute Women

    March 2001
    Nadia Saadat, Peyman Salehi, Azadeh Emami, A.R. Mortazavi
    Studysummary This study found that a 2% spironolactone cream, applied topically for 3 months, did not reduce hair growth in patients with facial hirsutism compared to untreated areas.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Read the full study on ijem.sbmu.ac.ir →
    Discuss this study in the Community →

    Related research 5

    1. The Hirsute Woman: Challenges in Evaluation and Management Endocrine Practice · 2011
    2. Cost-Effective Therapy in Patients with Idiopathic Hirsutism Expert review of pharmacoeconomics & outcomes research · 2004
    3. Comparison of Sequential Cyproterone Acetate/Estrogen Versus Spironolactone/Oral Contraceptive in the Treatment of Hirsutism ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1991
    4. Side Effects of Spironolactone Therapy in the Hirsute Woman ˜The œJournal of clinical endocrinology and metabolism/Journal of clinical endocrinology & metabolism · 1988
    5. Spironolactone Therapy for Hirsutism in a Hyperandrogenic Woman Annals of internal medicine · 1978